Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 2, 2010
Look-alike, sound-alike drugs in oncologyLaurel Kovacic, Carole Chambers
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 28, 2017
A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decisionLeanne Leung, Mário L de Lemos, Laurel Kovacic
International Journal of Technology Assessment in Health Care|September 6, 2017
COST-EFFECTIVENESS IMPACTS CANCER CARE FUNDING DECISIONS IN BRITISH COLUMBIA, CANADA, EVIDENCE FROM 1998 TO 2008Zahra Ismail, Stuart J Peacock, Laurel Kovacic, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 2, 2016
Adherence with capecitabine: A population-based analysis based on prescription refill dataLaurel Kovacic, Neil de Haan, Mário L de Lemos, et al.
The Oncologist|June 3, 2015
A Time-Trend Economic Analysis of Cancer Drug TrialsSonya Cressman, George P Browman, Jeffrey S Hoch, et al.
The Oncologist|June 12, 2010
Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomideChristina Kim, Christopher W Lee, Laurel Kovacic, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 23, 2009
Use of combined androgen blockade for advanced prostate cancer in British ColumbiaAdeline Chau, Mário L de Lemos, Tom Pickles, et al.
The Oncologist|February 4, 2012
Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancerLindsay Hedden, Susan O'Reilly, Caroline Lohrisch, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2012
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, CanadaLindsay Hedden, Hagen Kennecke, Diego Villa, et al.
Pageof 1